Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(23):1727; doi:10.1093/jnci/96.23.1727
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content

© 2004 Oxford University Press

IN THIS ISSUE

The first 10% of the full text of this article appears below.

{beta}-Carotene and Retinol Efficacy Trial Follow-Up

The {beta}-Carotene and Retinol Efficacy Trial, a randomized trial that tested the effect of daily {beta}-carotene and retinyl palmitate supplements on the incidence of lung cancer, other cancers, and death in participants who were at high risk for lung cancer because of a history of smoking or asbestos exposure, was stopped ahead of schedule because of a higher incidence of lung cancer, all-cause mortality, and cardiovascular disease mortality in the intervention arm. Goodman et al. (p. 1743) found that, 6 years after the discontinuation of the active intervention, participants who had received the . . . [Full Text of this Article]

Raloxifene and Breast Cancer

Risks of Tamoxifen Treatment in African American Women

Death Receptor Regulation and Celecoxib-Induced Apoptosis

Chlorpyrifos Exposure and Cancer Incidence

DNA Processing and Loss of p16INK4a and p19ARF